R&D Innovation
You are here: Home » About Us » R&D Innovation
Cosmetic Peptide Laboratory Research and Sample Preparation
WINKEY Cosmetic Raw Materials Laboratory Research
WINKEY Peptide Research Team Reviewing Laboratory Data
WINKEY Cosmetic Active Ingredients R&D Team
Skincare Ingredient Efficacy Evaluation and Skin Testing

Winkey R&D Innovation

For over 15 years, Winkey Technology has been dedicated to peptide innovation and sustainable raw material development, building an integrated R&D, production, and marketing strategic layout centered on peptide actives, characteristic botanical ingredients, biosynthesized materials, and sensory enhancers for personal care products.

Major Laboratories

 Quality Research Lab
 Biosynthesis Lab
 Biochemical Testing Lab
 Formulation Lab
 Polymer Chemical
Synthesis Lab
 Featured Resource
Development Lab
 Cell Biology Lab 
/ In Vitro Testing Lab
 Human Clinical Efficacy
Evaluation Lab

R&D System

Our R&D system is built on a robust, globally-integrated foundation. We have established two major R&D centers: the Skin Active Ingredients R&D Center in Shenzhen, China, and the Innovation Application R&D Center in Toulouse, France. This global presence is supported by our “1+3” Innovation R&D Platform, anchored by the Skin Active Peptide Research Institute and encompassing platforms for molecular innovation, synthetic biology, characteristic resource development, and carrier & formulation innovation. By 2026, the company has invested over 10% of its annual revenue in R&D on average, and established 8 major R&D laboratories with a total area of 15,000+ square meters, covering the entire value chain from molecular design to efficacy validation. The company has over 80 R&D personnel with pharmaceutical backgrounds, many of whom are doctoral graduates from Peking University and other prestigious institutions, with expertise in peptide drug chemistry, synthetic biology, and formulation sciences.
 8 Major R&D Laboratories
 300+ Innovative Molecular Structures in Reserve
 >10% R&D Investment Ratio (Annual Average)
 80+ R&D Personnel with Pharmaceutical Background
 15000+ m² R&D Laboratory Distinctive Flexible Pilot Platform

R&D Direction

Four Core Innovation Pillars Driving Peptide Breakthroughs

Driven by a commitment to innovation and sustainability, our R&D efforts are focused on four core pillars that are shaping the future of peptide science.

  • CADD & AIDD – Global Innovation Peptides
    We have pioneered the adoption of AI technology platforms from the pharmaceutical industry to drive the discovery of globally innovative peptides. By integrating Computer-Aided Drug Design (CADD) and AI-Assisted Drug Design (AIDD) with network pharmacology, we accelerate the development of novel active molecules that deliver high-efficacy, high-safety, and targeted skincare solutions for anti-aging, soothing and repair, brightening, and anti-hair loss applications.
  • Revolutionary Cyclic Peptide Library
    Moving beyond traditional acid-modified linear peptides, we are pioneering the next generation of cyclic peptide platforms. Our proprietary cyclic peptide technologies offer superior structural stability, enhanced target binding affinity, and improved bioavailability, unlocking new possibilities for peptide-based skincare innovation.
  • PDC Technology – Upgrading Classic Ingredients
    As a first mover in the personal care industry, we have introduced Peptide-Drug Conjugate (PDC) innovation technology from the pharmaceutical field to upgrade classic skincare ingredients. This cutting-edge approach enhances the efficacy and targeting precision of well-established active compounds, delivering next-level performance.
  • PFAS-Free Peptides – Green and Compliant
    We are a pioneer in developing PFAS-free peptide synthesis technologies, proactively addressing global regulatory trends toward environmental safety and sustainability. Our green peptide solutions ensure that customers receive high-performance ingredients that are fully compliant with evolving PFAS regulations.

Efficacy Evaluation System

Winkey has established a comprehensive efficacy evaluation system that covers the entire R&D process:

Mechanism

Establishing the cellular and molecular mechanisms underlying skin conditions

Markers

Identifying key biomarkers to reflect changes in skin efficacy
 

Models

Developing optimal in vitro and clinical models based on skin pathophysiology

Methods

Implementing validated detection methods at tissue, cellular, protein, and gene levels
0+
+
In Vitro Testing Models
0+
+
Advanced Testing Instruments
0+
+
Volunteer Efficacy Test Database

Future Outlook

Winkey Technology will continue to advance peptide innovation and sustainable raw material development. We remain committed to the discovery and industrialization of global first-in-class molecular structures, shortening R&D cycles through CADD and AIDD technologies, while intensifying research in cyclic peptides, PDC technology, and PFAS-free synthesis. Leveraging synthetic biology and green extraction, we will create eco-friendly active ingredients that address large-scale production and environmental compliance challenges, continuing to lead in the personal care ingredients field.

Quick Links

Product Category

...

Contact Us

Landline: +86-755-8695-1192
Tel: +86-177-2759-4013
E-mail: sales@winkey-china.com
Headquarters & R&D Add: 24th Floor, Building D3, Phase 2, Nanshan Zhiyuan, Taoyuan Street, Nanshan District, Shenzhen
Copyright © 2026 Winkey Technology Co., Ltd. All Rights Reserved. Sitemap | Privacy Policy